The lens is normally held in place behind the iris by tiny connective fibers called zonules. These fibers maintain proper lens alignment so light can be focused accurately. In dogs with PLL, a mutation—most commonly in the ADAMTS17 gene—weakens these zonular fibers. Over time, they break down, allowing the lens to shift from its normal position. The lens may move forward into the front chamber of the eye (anterior luxation) or backward into the vitreous (posterior luxation).
Clinical signs of Primary Lens Luxation typically appear in young to middle-aged dogs, depending on breed predisposition. Early symptoms may include mild eye redness, excessive tearing, squinting, or signs of discomfort. As the condition progresses, dogs may experience sudden pain, visible cloudiness in the eye, and noticeable changes in pupil appearance. If the lens moves forward, it can block normal fluid drainage inside the eye, leading to a rapid rise in intraocular pressure and secondary glaucoma. This can result in severe pain and irreversible vision loss if not treated quickly.
The PLL DNA Health Test is designed to detect the specific mutation in the ADAMTS17 gene associated with Primary Lens Luxation. The test is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine the dog’s genetic status. Since DNA remains unchanged throughout life, testing can be performed at any age, including before any clinical signs develop.
Results are generally reported in three categories:
- Clear (Normal): The dog does not carry the PLL mutation and is not expected to develop inherited lens luxation or pass it to offspring.
- Carrier: The dog carries one copy of the mutation but usually does not show clinical signs. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a high risk of developing Primary Lens Luxation during its lifetime.
Genetic testing for PLL is extremely important for breeders, veterinarians, and dog owners. Breeders can use results to make informed mating decisions that help reduce or eliminate the mutation from breeding populations while maintaining genetic diversity. Avoiding carrier-to-carrier breeding significantly reduces the risk of producing affected puppies.
For dog owners, knowing a dog’s genetic status allows for early eye health monitoring and prompt veterinary intervention if symptoms occur. Dogs identified as at risk should receive regular ophthalmic examinations to detect early lens instability and prevent complications such as glaucoma. In many cases, surgical treatment may be required to remove or reposition the lens and preserve vision.
The Primary Lens Luxation (PLL) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine ocular health, and helps reduce the impact of this inherited and potentially blinding eye disorder in future generations.
